Viewing StudyNCT04749173

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 3:44 PM
Last Modification Date: 2024-10-26 @ 1:56 PM
Study NCT ID: NCT04749173
Status: COMPLETED
Last Update Posted: 2021-12-13
First Post: 2021-01-20
Brief Title: To Assess the Safety Tolerability and Pharmacokinetic Properties of Niclosamide Injectable DWRX2003 Which is the Treatment of COVID-19 in Healthy Volunteers
Sponsor: Daewoong Pharmaceutical Co LTD
Organization: Daewoong Pharmaceutical Co LTD
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Covid19
Keywords: